Monograph Details
|
|
Respiratory Tract
> Asthma/COPD
|
|
INTAL |
| Manufacturer |
|
King Pharmaceuticals, Inc. |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Mast cell stabilizer. |
| Generic Name |
|
Cromolyn sodium 0.8mg/inh; metered dose inhaler. |
| Also |
|
• Cromolyn sodium Inh Soln
|
| Indications |
|
Asthma prophylaxis. Prevention of bronchoconstriction before exposure to a known precipitant (eg, exercise). |
| Adults and Children |
|
<5 years: not recommended. ≥5 years: 2 inh 4 times daily. Bronchoconstriction prevention: 2 inh 10–60 minutes before precipitant. |
| Precautions |
|
Not for treatment of acute attack. Impaired renal or hepatic function: reduce dose. Reevaluate if no improvement after 4 weeks. Avoid abrupt cessation. Discontinue if eosinophilic pneumonia occurs. Coronary artery disease or arrhythmias (Inhaler). Pregnancy (Cat.B). Nursing mothers. |
| Interactions |
|
Avoid use with isoproterenol during pregnancy. |
| Adverse Reactions |
|
Bronchospasm, throat irritation, bad taste, cough, wheezing, nasal congestion, anaphylaxis. |
| How Supplied |
Inhaler—8.1g (112 inh), 14.2g (200 inh)
Soln—contact supplier |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
